$Oncternal Therapeutics (ONCT.US)$Oncternal Therapeutics Has Been Granted U.S. Patent Number 12,128,026 Titled "Selective Androgen Receptor Degrader Ligands And Methods Of Use Thereof (For The Treatment Of Prostate Cancer)"
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Gambler007 : The message came out and there was no response
Trytosaveabit OP Gambler007 : Not much nope! Watching into AM and PM tomorrow
Gambler007 Trytosaveabit OP : 盘后能否动起来?
Trytosaveabit OP Gambler007 : Will see? Needs volume
Gambler007 Trytosaveabit OP : 谢谢
Trytosaveabit OP Gambler007 : You’re welcome